Home › Funds › Two Sigma Investments › TEVA
Two Sigma Investments position in TEVA
TEVA PHARMACEUTICAL-SP ADR · Health Care
Latest position (Q2 2026)271.59K sh
Reported value held$9.20M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 957.62K | $9.33M | New |
| Q4 2021 | 980.20K | $7.85M | Add |
| Q1 2022 | 517.05K | $4.86M | Reduce |
| Q2 2022 | 656.25K | $4.93M | Add |
| Q3 2022 | 5.28M | $42.64M | Add |
| Q4 2022 | 5.56M | $50.72M | Add |
| Q1 2023 | 1.15M | $10.17M | Reduce |
| Q2 2023 | 742.79K | $5.59M | Reduce |
| Q3 2023 | 152.97K | $1.56M | Reduce |
| Q4 2023 | 151.70K | $1.58M | Reduce |
| Q1 2024 | 133.75K | $1.89M | Reduce |
| Q2 2024 | 137.60K | $2.24M | Add |
| Q3 2024 | 715.15K | $12.89M | Add |
| Q4 2024 | 686.46K | $15.13M | Reduce |
| Q1 2025 | 136.80K | $2.10M | Reduce |
| Q1 2025 | 136.80K | $2.10M | Reduce |
| Q2 2025 | 319.89K | $5.36M | Add |
| Q2 2025 | 319.89K | $5.36M | Add |
| Q3 2025 | 120.40K | $2.43M | Reduce |
| Q4 2025 | 266.02K | $8.30M | Add |
| Q1 2026 | 366.79K | $11.05M | Add |
| Q2 2026 | 271.59K | $9.20M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TEVA
- BlackRock Inc 63.89M sh · $2.16B · Q2 2026
- Norges Bank Investment Management 32.30M sh · $1.09B · Q2 2026
- Fidelity Management & Research (FMR) 30.26M sh · $1.03B · Q2 2026
- Capital World Investors 12.54M sh · $424.72M · Q2 2026
- Geode Capital Management 11.61M sh · $391.01M · Q2 2026
- Northern Trust Corp 7.96M sh · $269.58M · Q2 2026
- Wellington Management Group 7.67M sh · $259.90M · Q2 2026
- Morgan Stanley 6.97M sh · $236.10M · Q2 2026
- Goldman Sachs Group 6.13M sh · $207.66M · Q2 2026
- Janus Henderson Group 4.82M sh · $145.08M · Q1 2026
- Bank of America Corp 4.23M sh · $143.23M · Q2 2026
- Millennium Management 3.98M sh · $134.81M · Q2 2026